641 related articles for article (PubMed ID: 19191898)
1. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.
Bogaerts P; Berhin C; Nizet H; Glupczynski Y
Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806
[TBL] [Abstract][Full Text] [Related]
3. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.
Miyachi H; Miki I; Aoyama N; Shirasaka D; Matsumoto Y; Toyoda M; Mitani T; Morita Y; Tamura T; Kinoshita S; Okano Y; Kumagai S; Kasuga M
Helicobacter; 2006 Aug; 11(4):243-9. PubMed ID: 16882327
[TBL] [Abstract][Full Text] [Related]
4. Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea.
Lee JW; Kim N; Nam RH; Park JH; Kim JM; Jung HC; Song IS
Helicobacter; 2011 Aug; 16(4):301-10. PubMed ID: 21762270
[TBL] [Abstract][Full Text] [Related]
5. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
[TBL] [Abstract][Full Text] [Related]
6. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
Chung JW; Lee GH; Jeong JY; Lee SM; Jung JH; Choi KD; Song HJ; Jung HY; Kim JH
J Gastroenterol Hepatol; 2012 Mar; 27(3):493-7. PubMed ID: 21793912
[TBL] [Abstract][Full Text] [Related]
7. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.
Kim JM; Kim JS; Kim N; Jung HC; Song IS
J Antimicrob Chemother; 2005 Nov; 56(5):965-7. PubMed ID: 16159928
[TBL] [Abstract][Full Text] [Related]
8. Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
Chang WL; Kao CY; Wu CT; Huang AH; Wu JJ; Yang HB; Cheng HC; Sheu BS
Helicobacter; 2012 Jun; 17(3):210-5. PubMed ID: 22515359
[TBL] [Abstract][Full Text] [Related]
9. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.
Wueppenhorst N; Stueger HP; Kist M; Glocker E
J Antimicrob Chemother; 2009 Apr; 63(4):648-53. PubMed ID: 19190100
[TBL] [Abstract][Full Text] [Related]
10. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.
Rimbara E; Noguchi N; Kawai T; Sasatsu M
Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614
[TBL] [Abstract][Full Text] [Related]
12. Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children.
Rozynek E; Dzierzanowska-Fangrat K; Celińska-Cedro D; Jóźwiak P; Madaliński K; Dzierzanowska D
Acta Microbiol Pol; 2002; 51(3):255-63. PubMed ID: 12588100
[TBL] [Abstract][Full Text] [Related]
13. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.
Hirata Y; Ohmae T; Yanai A; Sakitani K; Hayakawa Y; Yoshida S; Sugimoto T; Mitsuno Y; Akanuma M; Yamaji Y; Ogura K; Maeda S; Koike K
Int J Antimicrob Agents; 2012 Apr; 39(4):352-5. PubMed ID: 22321702
[TBL] [Abstract][Full Text] [Related]
14. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.
Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M
Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100
[TBL] [Abstract][Full Text] [Related]
15. Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period.
Oleastro M; Cabral J; Ramalho PM; Lemos PS; Paixão E; Benoliel J; Santos A; Lopes AI
J Antimicrob Chemother; 2011 Oct; 66(10):2308-11. PubMed ID: 21764826
[TBL] [Abstract][Full Text] [Related]
16. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
[TBL] [Abstract][Full Text] [Related]
17. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Yang JC; Lee PI; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1369-75. PubMed ID: 20658256
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M
Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin-resistant Helicobacter pylori in Hong Kong.
Lee CC; Lee VW; Chan FK; Ling TK
Chemotherapy; 2008; 54(1):50-3. PubMed ID: 18073471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
